How government can spark venture capital for biotech success

It’s best to put money in the game, but let the experts in the private sector decide on where to spend it, say industry reps.

University of Victoria researcher Martin Boulanger is partnering with Vancouver-based Zymeworks, which in June achieved the largest Canadian biotech initial public offering in a decade.Photograph courtesy of University of Victoria Photo Services

News

BY EMILY HAWS

September 20, 2017

As the government looks to shape its venture capital policy, biotechnology industry representatives say it’s important to minimize direct government intervention, instead letting the private sector decide what companies to invest in. The Venture Capital Catalyst Initiative (VCCI), as announced in...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy